Integer (ITGR) Competitors $121.73 +1.26 (+1.05%) Closing price 03:59 PM EasternExtended Trading$121.80 +0.07 (+0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ITGR vs. BDSX, ELV, BAX, HOLX, MASI, GMED, TFX, ATEC, ATRC, and IARTShould you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "medical" sector. Integer vs. Its Competitors Biodesix Elevance Health Baxter International Hologic Masimo Globus Medical Teleflex Alphatec AtriCure Integra LifeSciences Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations. Does the media refer more to ITGR or BDSX? In the previous week, Integer had 2 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for Integer and 0 mentions for Biodesix. Integer's average media sentiment score of 0.64 beat Biodesix's score of 0.00 indicating that Integer is being referred to more favorably in the media. Company Overall Sentiment Integer Positive Biodesix Neutral Do insiders and institutionals have more ownership in ITGR or BDSX? 99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 2.2% of Integer shares are owned by company insiders. Comparatively, 30.1% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend ITGR or BDSX? Integer presently has a consensus price target of $145.00, indicating a potential upside of 19.11%. Biodesix has a consensus price target of $1.75, indicating a potential upside of 468.18%. Given Biodesix's higher possible upside, analysts plainly believe Biodesix is more favorable than Integer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integer 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00Biodesix 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is ITGR or BDSX more profitable? Integer has a net margin of 4.38% compared to Biodesix's net margin of -54.28%. Integer's return on equity of 11.95% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Integer4.38% 11.95% 6.04% Biodesix -54.28%-167.28%-39.96% Which has more risk and volatility, ITGR or BDSX? Integer has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Biodesix has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Which has stronger valuation & earnings, ITGR or BDSX? Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInteger$1.72B2.47$119.90M$2.1157.69Biodesix$74.46M0.61-$42.93M-$0.29-1.06 SummaryInteger beats Biodesix on 15 of the 17 factors compared between the two stocks. Get Integer News Delivered to You Automatically Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ITGR vs. The Competition Export to ExcelMetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$4.25B$6.82B$5.57B$20.55BDividend YieldN/A1.29%5.25%3.74%P/E Ratio57.6925.5227.2128.04Price / Sales2.4794.23416.2641.55Price / Cash13.2720.6637.0622.25Price / Book2.524.778.084.61Net Income$119.90M$174.76M$3.16B$982.91M7 Day Performance0.61%1.48%3.74%3.25%1 Month Performance-0.67%0.51%3.88%4.36%1 Year Performance6.17%15.20%34.26%14.94% Integer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ITGRInteger3.6804 of 5 stars$121.73+1.0%$145.00+19.1%+4.7%$4.25B$1.72B57.6911,000BDSXBiodesix3.4039 of 5 stars$0.28+12.7%$1.75+520.1%-80.5%$36.69M$71.32M-0.97220ELVElevance Health4.9663 of 5 stars$389.42+2.1%$498.87+28.1%-34.6%$86.19B$177.01B15.19104,200Trending NewsUpcoming EarningsAnalyst ForecastBAXBaxter International4.2607 of 5 stars$30.33-0.2%$37.25+22.8%-12.2%$15.60B$10.64B-27.5738,000Analyst ForecastHOLXHologic4.7566 of 5 stars$65.16+0.2%$77.42+18.8%-11.9%$14.49B$4.03B27.497,063News CoveragePositive NewsAnalyst ForecastMASIMasimo3.7236 of 5 stars$168.22+0.0%$191.60+13.9%+54.7%$9.12B$2.09B-18.345,600News CoverageGMEDGlobus Medical4.9496 of 5 stars$58.98+0.6%$94.00+59.4%-16.2%$7.93B$2.52B44.015,300TFXTeleflex4.7316 of 5 stars$118.21-1.1%$164.63+39.3%-45.5%$5.28B$3.05B37.2914,100Positive NewsATECAlphatec4.3947 of 5 stars$11.10+0.2%$17.89+61.2%+6.0%$1.62B$611.56M-9.65700Positive NewsATRCAtriCure3.252 of 5 stars$32.77+1.5%$50.67+54.6%+43.5%$1.60B$465.31M-40.461,300Positive NewsIARTIntegra LifeSciences4.0846 of 5 stars$12.27-0.2%$18.63+51.8%-55.0%$955.08M$1.61B-32.294,396 Related Companies and Tools Related Companies BDSX Alternatives ELV Alternatives BAX Alternatives HOLX Alternatives MASI Alternatives GMED Alternatives TFX Alternatives ATEC Alternatives ATRC Alternatives IART Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ITGR) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integer Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.